Investigational Drug Information for ABI-H0731
✉ Email this page to a colleague
What is the drug development status for ABI-H0731?
ABI-H0731 is an investigational drug.
There have been 8 clinical trials for ABI-H0731.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 19th 2018.
The most common disease conditions in clinical trials are Hepatitis B, Chronic, Hepatitis B, and Hepatitis A. The leading clinical trial sponsors are Assembly Biosciences, Arbutus Biopharma Corporation, and [disabled in preview].
Summary for ABI-H0731
| US Patents | 0 |
| International Patents | 65 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2018-06-19) |
| Vendors | 26 |
Recent Clinical Trials for ABI-H0731
| Title | Sponsor | Phase |
|---|---|---|
| A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection | Arbutus Biopharma Corporation | Phase 2 |
| A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection | Assembly Biosciences | Phase 2 |
| A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection | Assembly Biosciences | Phase 2 |
Clinical Trial Summary for ABI-H0731
Top disease conditions for ABI-H0731
Top clinical trial sponsors for ABI-H0731
US Patents for ABI-H0731
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ABI-H0731
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ABI-H0731 | Argentina | AR106037 | 2035-09-15 | ⤷ Sign Up |
| ABI-H0731 | Argentina | AR106040 | 2035-09-15 | ⤷ Sign Up |
| ABI-H0731 | Argentina | AR106041 | 2035-09-15 | ⤷ Sign Up |
| ABI-H0731 | Australia | AU2016323293 | 2035-09-15 | ⤷ Sign Up |
| ABI-H0731 | Australia | AU2016323297 | 2035-09-15 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
